Transcriptomic and Quantitative Proteomic Analysis of Transporters and Drug Metabolizing Enzymes in Freshly Isolated Human Brain Microvessels
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
We have investigated the transcriptomic and/or proteomic patterns of 71 solute carrier (SLC) and organic solute (OST) transporters, 34 ATP-binding cassette (ABC) transporters, and 51 metabolizing enzymes in human brain microvessels. We used quantitative RT-PCR and LC-MS/MS to examine isolated brain microvessels and cortex biopsies from 12 patients with epilepsia or glioma. SLC2A1/GLUT1, SLC1A3/EAAT1, and SLC1A2/EAAT2 were the main SLC proteins whereas ABCG2/BCRP, ABCB1/MDR1, ABCA2 and ABCA8 were the main ABC quantified in isolated brain microvessels; ABCG2/BCRP was 1.6-fold more expressed than ABCB1/MDR1, and ABCC4/MRP4 was 10 times less abundant than ABCB1/MDR1. CYP1B1 and CYP2U1 were the only quantifiable CYPs. Finally, GSTP1, COMT, GSTM3, GSTO1 and GSTM2 proteins were the main phase II enzymes quantified; UGTs and NATs were not detected. Our extensive investigation of gene and protein patterns of transporters and metabolizing enzymes provides new molecular information for understanding drug entry and metabolism in the human blood-brain barrier.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most efforts to combine transcriptomic and proteomic profiling have compared or validated the expression of genes via the abundance of their RNAs and proteins, including characterisation of abundance across healthy tissues45, changes due to neurological disorders46, and localised expression in neuronal processes47.”
From Decoding neuroproteomics: integrating the genome, translatome and functional anatomy (2014) · cites this paper as [46]
Citations
Cites
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,261
Chen, J., Lipska, B. K., Halim, N., Ma, Q. D., Matsumoto, M., Melhem, S., Kolachana, B. S., Hyde, T. M., Herman, M. M., Apud, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/425589 · Cited by 1,675
Induction of phase I, II and III drug metabolism/transport by xenobiotics
Xu, C., Li, C. Y.-T., & Kong, A.-N. T. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02977789 · Cited by 1,279
Hediger, M. A., Romero, M. F., Peng, J.-B., Rolfs, A., Takanaga, H., & Bruford, E. A. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1192-y · Cited by 985
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
Uchida, Y., Ohtsuki, S., Katsukura, Y., Ikeda, C., Suzuki, T., Kamiie, J., & Terasaki, T. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07208.x · Cited by 881
Self-citationBlood-brain barrier active efflux transporters: ATP-binding cassette gene family
Löscher, W., & Potschka, H. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.86 · Cited by 872
Kamiie, J., Ohtsuki, S., Iwase, R., Ohmine, K., Katsukura, Y., Yanai, K., Sekine, Y., Uchida, Y., Ito, S., & Terasaki, T. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9532-4 · Cited by 478
Self-citationTransporting therapeutics across the blood-brain barrier
Abbott, N. J., & Romero, I. A. (1996) · Molecular Medicine Today · doi:10.1016/1357-4310(96)88720-x · Cited by 447
Polymorphisms in Human Organic Anion-transporting Polypeptide 1A2 (OATP1A2)
Lee, W., Glaeser, H., Smith, L. H., Roberts, R. L., Moeckel, G. W., Gervasini, G., Leake, B. F., & Kim, R. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411092200 · Cited by 365
Functional Characterization of pH-Sensitive Organic Anion Transporting Polypeptide OATP-B in Human
Nozawa, T., Imai, K., Nezu, J.-I., Tsuji, A., & Tamai, I. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060194 · Cited by 351
Research works printed but not linked: 3
- Hagenbuch B., 2002, News Physiol. Sci., 17, 231
- Martinasevic M. K., 1998, Drug Metab. Dispos., 26, 1039
- Cornford E. M., 1992, Cancer Res., 52, 138
Cited by
Items 301–400 of 400
From blood to brain through BBB and astrocytic signaling
Pan, W. (2015) · Peptides · doi:10.1016/j.peptides.2015.06.003 · Cited by 5
Role of multidrug resistance in glioblastoma chemoresistance: Focus on ABC transporters
Ahmed, M. H., Verreault, M., Declèves, X., & Idbaïh, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821567-8.00025-7 · Cited by 7
Self-citationSangha, V., Williams, E. I., Ronaldson, P. T., & Bendayan, R. (2022) · Wiley eBooks · doi:10.1002/9781119739883.ch14 · Cited by 6
Uchida, Y., Tachikawa, M., Ohtsuki, S., & Terasaki, T. (2013) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-9105-7_3 · Cited by 8
“81 fmol/μg protein, a level similar to that of asct2 in mouse brain capillaries (Table 3.3; Shawahna et al. 2011).”
BackgroundInfluentialSelf-citationJiang, J., Luo, L., Zhang, Z., Liu, X., Chen, N., Li, Y., & Li, S. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16030330 · Cited by 4
“In the SH-SY5Y and hCMEC/D3 cell systems, IMM-H004G was not detected, while in the HEB system, the production of IMM-H004G depended on both time and concentration cells for 24 h, no It was reported that human brain microvessels did not exhibit obvious expression of any UGT genes [33].”
BackgroundZhang, X., Zhu, X., & Shi, Q. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1432878 · Cited by 4
Molecular determinants of neuroprotection in blood-brain interfaces of the cynomolgus monkey
Strazielle, N., Blondel, S., Confais, J., Khoury, R. E., Contamin, H., & Ghersi‐Egea, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1523819 · Cited by 4
Disdier, C., & Stonestreet, B. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813146-6.00024-2 · Cited by 4
Does nonlinear blood-brain barrier transport matter for (lower) morphine dosing strategies?
Gülave, B., Budda, D., Saleh, M. A. A., van Hasselt, J. G. C., & de Lange, E. C. M. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106482 · Cited by 4
Sóskuti, E., Szilvásy, N., Temesszentandrási‐Ambrus, C., Urbán, Z., Csíkvári, O., Szabó, Z., Kecskeméti, G., Pusztai, É., & Gáborik, Z. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060736 · Cited by 4
“…data about MDR1 from human and preclinical species on quantitative transport, affinity to various transporters and transporter abundance [1,4–7, The major pharmacological factor that needs to be optimized in CNS drug discovery is K p,uu,brain (unbound brain-to-plasma partition coefficient),…”
BackgroundAsymptomatic ST segment elevation.
MacKenzie, R. (2004) · PubMed · Cited by 4
Biomarker-Guided Drug Delivery Systems and Oral Bioavailability Enhancement
Vo, D.-K., & Duong, V. (2026) · Pharmaceuticals · doi:10.3390/ph19030454 · Cited by 3
“Genomic and transcriptomics tools, like next-generation sequencing (NGS) and quantitative polymerase chain reaction (PCR), are valuable for profiling the expression of drug transporters and metabolizing enzymes, as well as identifying genetic polymorphisms [43,44].”
Wellens, S., Gosselet, F., & Culot, M. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105424 · Cited by 3
Drug Delivery to Primary and Metastatic Brain Tumors: Challenges and Opportunities
Talele, S., Mohammad, A. S., Schulz, J., Bauer, B., Hartz, A. M. S., Sarkaria, J. N., & Elmquist, W. F. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_24 · Cited by 3
Peptides and Their Delivery to the Brain
Elballa, W. M., Schwinghamer, K., Ebert, E., & Siahaan, T. J. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-031-04544-8_7 · Cited by 3
Lahmann, C., Kramer, H., & Ashcroft, F. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215989 · Cited by 3
Material considerations for delivering therapeutics across the blood–brain barrier
Zoba, A. N., & Tringides, C. M. (2025) · APL Materials · doi:10.1063/5.0284305 · Cited by 2
Human bone marrow-mesenchymal stem cells differentiation into brain-like endothelial cells
Soliman, Y., BARAN, G., & Mustafaoğlu, N. (2026) · TURKISH JOURNAL OF BIOLOGY · doi:10.55730/1300-0152.2786 · Cited by 2
“Additionally, BMECs express broad-spectrum efflux pumps that limit the uptake of lipid-soluble compounds into the brain, including numerous drugs (Mahringer et al., 2011; Shawahna et al., 2011).”
Gulabrai-Díaz, S., Escudero‐López, B., del Río, C., Montaner, J., Berzaghi, M., Mena, P. R., Troncoso, A. M., & Ortega, R. H. (2026) · Food & Function · doi:10.1039/d6fo00323k · Cited by 2
Pharmacoproteomic Approach by Quantitative Targeted Proteomics
Ohtsuki, S. (2012) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.132.479 · Cited by 3
Self-citationIn Vitro Models of CNS Barriers
Abbott, N. J., Yusof, S. R., Reichel, A., Dolman, D. E. M., & Preston, J. E. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_8 · Cited by 6
Molecular and Cellular Mechanism of Pathogen Invasion into the Central Nervous System: Meningitis
Singh, P., Gupta, K. C., Sharma, M., & Kumar, S. (2024) · Springer eBooks · doi:10.1007/978-981-99-9404-5_14 · Cited by 5
Barriers of the CNS and Their Contribution to Drug-Resistant Epilepsy
Díaz-Coránguez, M., Auzmendi, J., Fuentes-Mejía, M., Cosme, T. M., Lazarowski, A., & Rocha, L. (2024) · AAPS introductions in the pharmaceutical sciences · doi:10.1007/978-3-031-62604-3_8 · Cited by 3
Physiologically Based Pharmacokinetic Modelling in Drug Delivery
Badhan, R. K. S. (2015) · Wiley eBooks · doi:10.1002/9781118573983.ch13 · Cited by 2
Sojo, L. E., Kwan, R., Dang, C., Tung, M., & Li, J. (2019) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.8398 · Cited by 2
Di, L., & Kerns, E. H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801076-1.00009-5 · Cited by 2
Emerging strategies to treat the brain, behind its barrier
Little, W., & Davies, C. H. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.044 · Cited by 3
Mészáros, M. (2019) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.10157 · Cited by 2
Torres‐Vergara, P., Rivera, R., Escudero, C., & Penny, J. I. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-32554-0_7 · Cited by 1
Gut Microbiome Strategies for Enhancing ICI Delivery Across the BBB in Glioblastoma
Barati, S., Ghoflchi, S., Nakhaei, A., Yazdi, M., Hosseinzadeh, P., Hosseini, H., & Jalili‐Nik, M. (2026) · BioFactors · doi:10.1002/biof.70077 · Cited by 1
Sun, M., Lynch, K., Mariager, T., Bodilsen, J., Nau, R., van Wijk, R. C., Manson, M. L., de Lange, E. C. M., & Guo, T. (2026) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2026.107478 · Cited by 1
Applications of Targeted Proteomics in ADME for IVIVE
Balogh, L. M., & Lai, Y. (2013) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-8229-1_5 · Cited by 1
In Vivo Studies of Drug BBB Transport: Translational Challenges and the Role of Brain Imaging
Syvänen, S., Hammarlund‐Udenaes, M., & Loryan, I. (2020) · Handbook of experimental pharmacology · doi:10.1007/164_2020_425 · Cited by 1
Drug Metabolism at the Blood-Brain and Blood-CSF Barriers
Ghersi‐Egea, J., Strazielle, N., & Declèves, X. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_6 · Cited by 1
Self-citationTalevi, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-36526-3_20 · Cited by 2
In Vitro Blood–Brain Barrier Studies
Agarwal, R., Hanjankar, S. N., Dhikale, A., & Patravale, V. B. (2024) · AAPS introductions in the pharmaceutical sciences · doi:10.1007/978-3-031-62604-3_3 · Cited by 1
Harwood, M. D. (2015) · Research Explorer (The University of Manchester) · Cited by 2
Lindqvist, A. (2015) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 2
Modulation of the Tumor Microenvironment To Overcome Glioblastoma Treatment Resistance
Ahmed, M. H. (2021) · theses.fr (ABES) · doi:10.70675/25ed4d34z9ef1z4b7bza992z41c9ad48acaf · Cited by 1
The role of brain and intestinal efflux transporters in disposition of central nervous system drugs
Wittgen, H. G. M. (2012) · Radboud Repository (Radboud University)
Role of Biotechnology in Drug Delivery to the Nervous System
Jain, K. K. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-272-8_13 · Cited by 1
An Insect-Based Ex Vivo Blood Brain
Al‐Qadi, S., & Schiøtt, M. (2014)
Role of TTR in A β peptide brain efflux - Impact in Alzheimer's disease
Gaiteiro, C. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/akv8-d088
Järvinen, E. (2016) · Helda - University of Helsinki Institutional Repository
Tachikawa, M., Uchida, Y., & Terasaki, T. (2013) · Drug Delivery System · doi:10.2745/dds.28.270
Self-citationGantner, M. E. (2016) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/57704 · Cited by 1
“2.3.2 Evidencia clínica En cuanto a los datos clínicos, se ha acumulado una gran cantidad de evidencia que demuestra altos niveles de expresión de los transportadores ABC (particularmente de Pgp, BCRP y varios miembros de las MRP) en la unidad neurovascular, ya sea a nivel de la BHE, las células de la glía o las neuro…”
BackgroundInfluentialRegulation of ABCB1 expression and activity in porcine brain endothelial cells
Vergara, P. (2016) · Research Explorer (The University of Manchester)
Structure-Activity Relationships of Efflux Transporter Inhibitors
Deng, F. Y. (2019) · Helda - University of Helsinki Institutional Repository
Methodological developments in small animal PET neuroimaging
Tóth, M. (2015) · Figshare
Quantifying drug metabolizing enzymes and transporters by LC-MS/MS proteomics
Zhang, H., Basit, A., & Prasad, B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820018-6.00012-0
Transport of statins by human ABC efflux transporters in vitro
Tuomi, S.-K. (2021) · UTUPub (University of Turku)
伊藤, 守. (1992) · 文経論叢
Pereira, J. N. S. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4917
Approaches Towards Prediction of CNS PK and PD
de Lange, E. C. M., Chang, H. Y., & Shah, D. K. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_12
Di, L. (2022) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2342
“…major breakthrough in the past decade (Al Feteisi et al., 2018; Al ‐ Majdoub et al., 2019; Bao et al., 2020; Bill-ington et al., 2019; Gomez ‐ Zepeda et al., 2019; Hoshi et al., 2013; Ohtsuki et al., 2013; Sato et al., 2021; Shawahna et al., 2011; Storelli et al., 2021; Uchida et al., 2011, 2020).”
BackgroundCegarra, C. (2022) · theses.fr (ABES) · doi:10.70675/a88ce275zc265z4d42zbd24z29c3fcb1cd8b
Choublier, N. (2021) · theses.fr (ABES) · doi:10.70675/c24c7ff2z2531z4aa4z8aeaz1b3246b5d330
Transporter-Mediated Drug Delivery to the Brain
Puris, E., Gynther, M., & Fricker, G. (2024) · AAPS introductions in the pharmaceutical sciences · doi:10.1007/978-3-031-62604-3_1
Challenges of Brain Targeting and Mechanism of Drug Transfer Across Brain Barriers
Duarte, A. C., Mineiro, R., Santos, C. R. A., Costa, D. R. B., & Quintela, T. (2024) · Springer eBooks · doi:10.1007/978-981-97-2859-6_2
Setó‐Salvia, N., Houlden, H., & Warner, T. T. (2025) · BMC Medical Genomics · doi:10.1186/s12920-025-02249-7
“The role of SLC47A1 could be involved in the efflux of organic cations and cationic drugs [60] but, its association with dystonia is still unknown.”
Jezierski, A., Huang, J., Haqqani, A. S., Haukenfrers, J., Liu, Z., Baumann, E., Sodja, C., Charlebois, C., Delaney, C. E., Star, A. T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26592191
Jezierski, A., Huang, J., Haqqani, A. S., Haukenfrers, J., Liu, Z., Baumann, E., Sodja, C., Charlebois, C., Delaney, C. E., Star, A. T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26592188
Distribution of DNA Damage Response Inhibitors to the Central Nervous System for Brain Tumor Therapy
Talele, S. (2022) · University of Minnesota Digital Conservancy (University of Minnesota)
Dubinsky, S., McIntyre, M. T., Kim, M., Hawryluck, L., & Edginton, A. N. (2026) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-025-00981-0
Vandenhaute, E. (2011) · theses.fr (ABES) · doi:10.70675/fc4ed0aazbe21z4462zaf3cz403a50314e96 · Cited by 5
“…et transcriptionnelles ont d’ailleurs démontré qu’elle constituerait la pompe d’efflux la plus exprimée au niveau de la BHE - devant la P-gp - chez l’Homme (Dauchy et al., 2008; Shawahna et al., 2011; Uchida et al., 2011), le macaque (Ito et al., 2011) et le porc (Eisenblätter et al., 2003).”
BackgroundTrotier-Faurion, A. (2013) · theses.fr (ABES) · doi:10.70675/88744a8azcb26z49dbz977az6bf9162d955c
Jacob, A. (2012) · theses.fr (ABES) · doi:10.70675/853d8a51z7d47z43f9zb950zbf7ef1fd9406
Self-citationGomez‐Zepeda, D. (2016) · theses.fr (ABES) · doi:10.70675/201eb262zd087z47f7zb80az270680968460
Etudes biochimiques et structurales d'un cytochrome P450 orphelin de cerveau humain, le CYP2U1
Dhers, L. (2016) · theses.fr (ABES) · doi:10.70675/dcd5067dza8d2z4277z9a05z2fa12d9485f0
Complexes métalliques pour utilisation en imagerie médicale : application à la maladie d’Alzheimer
Porqueras, D. S. D. (2016) · theses.fr (ABES) · doi:10.70675/b908263ez07c9z441ez94d8zc53fbd818c56 · Cited by 2
Dréan, A. (2018) · theses.fr (ABES) · doi:10.70675/4f15a9f7z92e6z4973z9e0bz065b3edec352
“SLC2A1 (Glucose transporter 1, GLUT-1), involved in the crossing of glucose, is one of the mostabundant transporters of the SLC family [4,8,9].”
BackgroundPhenolic Compound Transport from Gut to Brain: Their Chemical Interactions and Transport Pathways
Delgado, F. J. P., Domínguez-Avila, J. A., González-Aguilar, G. A., Ayala-Zavala, J. F., Villegas‐Ochoa, M. A., Martínez-Martínez, A., Preciado-Saldaña, A. M., García‐Villa, D., & Montiel‐Herrera, M. (2026) · Compounds · doi:10.3390/compounds6020025 · Cited by 1
“Brain endothelial cells express enzymes like COMT, UGT, and methyltransferases that produce chemical modifications by the addition of different functional groups [86,87].”
Khoury, R. E. (2025) · theses.fr (ABES) · doi:10.70675/f6bfabdaz017dz4077z875ezddaf3e965c92
Identification fonctionnelle et moléculaire d'un transporteur de psychotropes et substances d'abus
Chapy, H. (2015) · theses.fr (ABES) · doi:10.70675/c2ac2638zf52dz4a3bzb797z80cfc4354123
Gerhartl, A., Kirchsteiger, M., Brachner, A., Czeloth, L., Valentova, B., Duarte, I. F., & Neuhaus, W. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18070817
Jung, E., Jeong, H. C., & Lee, K. (2026) · Organoid · doi:10.51335/organoid.2026.6.e9
Hernández, A. F., Darney, K., Dorne, J. L. C. M., Metruccio, F., Paini, A., Testai, E., & Louisse, J. (2026) · Computational Toxicology · doi:10.1016/j.comtox.2026.100448
BindingDB (2022) · UC San Diego · doi:10.7270/q2mp56xk
Cegarra, C., Cameron, B., Chaves, C., Dabdoubi, T., Do, T.-M., Genêt, B., Roudières, V., Shi, Y., Tchepikoff, P., & Lesuisse, D. (2022) · doi:10.1371/journal.pone.0274667.r005
Ali, A. (2014) · theses.fr (ABES) · doi:10.70675/40699b11za434z4468zb817zed9f95ce71a6 · Cited by 1
Metadata
- Authors
- Shawahna, R., Uchida, Y., Declèves, X., Ohtsuki, S., Yousif, S., Dauchy, S., Jacob, A., Chassoux, F., Daumas-Duport, C., Couraud, P.-O., Terasaki, T., & Scherrmann, J.-M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Tohoku University (JP)
- Centre Hospitalier Sainte-Anne (FR)
- Ste Anne Hospital, Paris, France
- Inserm (FR)
- Corresponding author
- Declèves, Xavier
- ORCID
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2011-07-08
- Volume
- 8
- Issue
- 4
- Pages
- 1332-1341
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W2090945850
- Cited by
- 372
- References
- 48
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 23 · 2023: 19 · 2022: 27 · 2021: 26 · 2020: 31 · 2019: 20 · 2018: 30 · 2017: 29 · 2016: 29 · 2015: 35 · 2014: 27 · 2013: 32 · 2012: 24
- FWCI
- 13.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (23790170)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- cerebral microvasculature, blood-brain barrier, solute carrier transporters, organic cation transporters, ABC transporters, drug-metabolizing enzymes, drug transporters, GLUT1, GLAST, GLT-1, MDR1/ABCB1, ABCA2, ABCA8, CYP1B1, CYP2U1, glutathione S-transferase, catechol-O-methyltransferase, glioma
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily G, Member 2, Brain, Chromatography, Liquid, Glutathione Transferase, Humans, Neoplasm Proteins, ATP Binding Cassette Transporter, Subfamily B, ATP-Binding Cassette Transporters, ATP Binding Cassette Transporter, Subfamily B, Member 1, Excitatory Amino Acid Transporter 1, Excitatory Amino Acid Transporter 2, Proteomics, Glutamate Plasma Membrane Transport Proteins, Glucose Transporter Type 1, Glutathione S-Transferase pi, Tandem Mass Spectrometry, Microvessels, Transcriptome, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.